Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)
- DOI
- 10.1002/ajh.70474
- Published
- 2026-08-27
- Container
- American Journal of Hematology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/ajh.70474,
title = {Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)},
author = {Benjamin Rolles and Jan Philipp Bewersdorf and Tariq Kewan and Ondrej Blaha and Jessica M. Stempel and Luca Lanino and Najla H. Al Ali and Amy E. DeZern and Mikkael A. Sekeres and Geoffrey L. Uy and Samuel Urrutia and Hetty E. Carraway and Pinkal Desai and Elizabeth A. Griffiths and Eytan M. Stein and Andrew M. Brunner and Christine McMahon and Rory M. Shallis and Joshua F. Zeidner and Michael R. Savona and Shougat Barua and Namrata Sonia Chandhok and Constantine Logothetis and Aram Bidikian and Ted M. Getz and Gail J. Roboz and Eunice S. Wang and Amyah C. Harris and Maria L. Amaya and Hayley Hawkins and Somedeb Ball and Justin Grenet and Parisa Abedi and Shai Shimony and R. Coleman Lindsley and Zhuoer Xie and Yazan F. Madanat and Yasmin Abaza and Talha Badar and Torsten Haferlach and Jaroslaw P. Maciejewski and David Sallman and Anoop Enjeti and Kamal Al‐Rabi and Khalid Halahleh and Devendra Hiwase and Maria Diez‐Campelo and David Valcarcel and Claudia Haferlach and Lisa Pleyer and Ioannis Kotsianidis and Vasiliki Pappa and Valeria Santini and Angela Consagra and Aref Al‐Kali and Seishi Ogawa and Yasuhito Nannya and Matteo Giovanni Della Porta and Rami S. Komrokji and Amer M. Zeidan and Maximilian Stahl},
year = {2026},
journal = {American Journal of Hematology},
doi = {10.1002/ajh.70474},
url = {https://doi.org/10.1002/ajh.70474}
}RIS
TY - JOUR TI - Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS) AU - Benjamin Rolles AU - Jan Philipp Bewersdorf AU - Tariq Kewan AU - Ondrej Blaha AU - Jessica M. Stempel AU - Luca Lanino AU - Najla H. Al Ali AU - Amy E. DeZern AU - Mikkael A. Sekeres AU - Geoffrey L. Uy AU - Samuel Urrutia AU - Hetty E. Carraway AU - Pinkal Desai AU - Elizabeth A. Griffiths AU - Eytan M. Stein AU - Andrew M. Brunner AU - Christine McMahon AU - Rory M. Shallis AU - Joshua F. Zeidner AU - Michael R. Savona AU - Shougat Barua AU - Namrata Sonia Chandhok AU - Constantine Logothetis AU - Aram Bidikian AU - Ted M. Getz AU - Gail J. Roboz AU - Eunice S. Wang AU - Amyah C. Harris AU - Maria L. Amaya AU - Hayley Hawkins AU - Somedeb Ball AU - Justin Grenet AU - Parisa Abedi AU - Shai Shimony AU - R. Coleman Lindsley AU - Zhuoer Xie AU - Yazan F. Madanat AU - Yasmin Abaza AU - Talha Badar AU - Torsten Haferlach AU - Jaroslaw P. Maciejewski AU - David Sallman AU - Anoop Enjeti AU - Kamal Al‐Rabi AU - Khalid Halahleh AU - Devendra Hiwase AU - Maria Diez‐Campelo AU - David Valcarcel AU - Claudia Haferlach AU - Lisa Pleyer AU - Ioannis Kotsianidis AU - Vasiliki Pappa AU - Valeria Santini AU - Angela Consagra AU - Aref Al‐Kali AU - Seishi Ogawa AU - Yasuhito Nannya AU - Matteo Giovanni Della Porta AU - Rami S. Komrokji AU - Amer M. Zeidan AU - Maximilian Stahl PY - 2026 JO - American Journal of Hematology DO - 10.1002/ajh.70474 UR - https://doi.org/10.1002/ajh.70474 ER -
APA
Rolles, B., Bewersdorf, J. P., Kewan, T., Blaha, O., Stempel, J. M., Lanino, L., Ali, N. H. A., DeZern, A. E., Sekeres, M. A., Uy, G. L., Urrutia, S., Carraway, H. E., Desai, P., Griffiths, E. A., Stein, E. M., Brunner, A. M., McMahon, C., Shallis, R. M., Zeidner, J. F., Savona, M. R., Barua, S., Chandhok, N. S., Logothetis, C., Bidikian, A., Getz, T. M., Roboz, G. J., Wang, E. S., Harris, A. C., Amaya, M. L., Hawkins, H., Ball, S., Grenet, J., Abedi, P., Shimony, S., Lindsley, R. C., Xie, Z., Madanat, Y. F., Abaza, Y., Badar, T., Haferlach, T., Maciejewski, J. P., Sallman, D., Enjeti, A., Al‐Rabi, K., Halahleh, K., Hiwase, D., Diez‐Campelo, M., Valcarcel, D., Haferlach, C., Pleyer, L., Kotsianidis, I., Pappa, V., Santini, V., Consagra, A., Al‐Kali, A., Ogawa, S., Nannya, Y., Porta, M. G. D., Komrokji, R. S., Zeidan, A. M., & Stahl, M. (2026). Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS). American Journal of Hematology. https://doi.org/10.1002/ajh.70474
Source records
- crossref · retrieved 2026-09-25T22:48:52.476Z